{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer activity", "apoptosis", "derivatives", "fangchinoline"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29117113", "DateCompleted": {"Year": "2018", "Month": "07", "Day": "09"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "31"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "11", "Day": "08"}], "Language": ["eng"], "ELocationID": ["1923", "10.3390/molecules22111923"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "22", "Issue": "11", "PubDate": {"Year": "2017", "Month": "Nov", "Day": "08"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives.", "Abstract": {"AbstractText": ["Twenty fangchinoline derivatives were synthesized from the natural product fangchinoline, and their anticancer activities on human breast cancer MDA-MB-231 cell line, human prostate cancer PC3 cell line, human melanoma WM9 cell line and human leukaemia HEL and K562 cell lines were evaluated. The biological result showed that those derivatives exhibited potent activities on inhibiting cancer cell growth, and the structure-activity relationships were investigated. Among them, compound <b>4g</b>, which was protected by benzoyl group in 7-phenolic position and nitrified in 14-position, showed impressive inhibition on all 5 cancer cell lines, especially WM9 cell line, with an IC<sub>50</sub> value of 1.07 \u00b5M. Further mechanistic studies demonstrated that compound <b>4g</b> may induce cancer cell death by apoptotic means. These research results suggested that compound <b>4g</b> could be a lead for the further development toward an anticancer agent against human melanoma WM9 in the future."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. liuyazi19@gmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. liuyazi19@gmail.com."}], "LastName": "Liu", "ForeName": "Yazhou", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. m18311511109@163.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. m18311511109@163.com."}], "LastName": "Xia", "ForeName": "Bin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. lanjunjie2007@163.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. lanjunjie2007@163.com."}], "LastName": "Lan", "ForeName": "Junjie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. husheng0221@gmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. husheng0221@gmail.com."}], "LastName": "Hu", "ForeName": "Shengcao", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. huanglan0612@163.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. huanglan0612@163.com."}], "LastName": "Huang", "ForeName": "Lan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. cc283818640@163.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. cc283818640@163.com."}], "LastName": "Chen", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. xueyizeng@126.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. xueyizeng@126.com."}], "LastName": "Zeng", "ForeName": "Xueyi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. loouhy@126.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. loouhy@126.com."}], "LastName": "Lou", "ForeName": "Huayong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. linchanghu79@sina.com."}], "LastName": "Lin", "ForeName": "Changhu", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, 3491 Baijin Road, Guiyang 550014, China. wdpan@163.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, 3491 Baijin Road, Guiyang 550014, China. wdpan@163.com."}], "LastName": "Pan", "ForeName": "Weidong", "Initials": "W"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "953592C3ZB", "NameOfSubstance": "fangchinoline"}], "MeshHeadingList": [{"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Drug Screening Assays, Antitumor"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "K562 Cells"}, {"QualifierName": ["drug therapy", "metabolism", "pathology"], "DescriptorName": "Melanoma"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "World Health Organization . World Health Statistics 2016: Monitoring Health for the SDGs Sustainable Development Goals. WHO Press; Geneva, Switzerland: 2016. Implications of the SDGs for health monitoring\u2014A challenge and an opportunity for all countries."}, {"Citation": "McGuire S. World cancer report 2014. Geneva, Switzerland: World health organization, international agency for research on cancer, who press, 2015. Adv. Nutr. 2016;7:418\u2013419. doi: 10.3945/an.116.012211.", "ArticleIdList": ["10.3945/an.116.012211", "PMC4785485", "26980827"]}, {"Citation": "Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA Cancer J. Clin. 2015;65:87\u2013108. doi: 10.3322/caac.21262.", "ArticleIdList": ["10.3322/caac.21262", "25651787"]}, {"Citation": "Ferr\u00e1n C.L., Seisdedos R.T. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: A systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1545\u20131602.", "ArticleIdList": ["PMC5055577", "27733282"]}, {"Citation": "Sternberg C.N., Donat S.M., Bellmunt J., Millikan R.E., Stadler W., De Mulder P., Sherif A., von der Maase H., Tsukamoto T., Soloway M.S. Chemotherapy for bladder cancer: Treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology. 2007;69:62\u201379. doi: 10.1016/j.urology.2006.10.041.", "ArticleIdList": ["10.1016/j.urology.2006.10.041", "17280909"]}, {"Citation": "Zagouri F., Peroukidis S., Tzannis K., Kouloulias V., Bamias A., Hellenic Genito-Urinary Cancer Group Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: A systematic review and critical evaluation by the hellenic genito-urinary cancer group (hgucg) Crit. Rev. Oncol. Hematol. 2015;93:36\u201349.", "ArticleIdList": ["25205597"]}, {"Citation": "Newman D.J. Natural products as leads to potential drugs: An old process or the new hope for drug discovery? J. Med. Chem. 2008;51:2589\u20132599. doi: 10.1021/jm0704090.", "ArticleIdList": ["10.1021/jm0704090", "18393402"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 2007;70:461\u2013477. doi: 10.1021/np068054v.", "ArticleIdList": ["10.1021/np068054v", "17309302"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Fabricant D.S., Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health Perspect. 2001;109(Suppl. 1):69\u201375. doi: 10.1289/ehp.01109s169.", "ArticleIdList": ["10.1289/ehp.01109s169", "PMC1240543", "11250806"]}, {"Citation": "Fang L.H., Zhang Y.H., Ku B.S. Fangchinoline inhibited the antinociceptive effect of morphine in mice. Phytomedicine. 2005;12:183\u2013188. doi: 10.1016/j.phymed.2003.06.007.", "ArticleIdList": ["10.1016/j.phymed.2003.06.007", "15830839"]}, {"Citation": "Jiang M., Zhang R., Wang Y., Jing W., Liu Y., Ma Y., Sun B., Wang M., Chen P., Liu H., et al. Reduction-sensitive paclitaxel prodrug self-assembled nanoparticles with tetrandrine effectively promote synergistic therapy against drug-sensitive and multidrug-resistant breast cancer. Mol. Pharm. 2017 doi: 10.1021/acs.molpharmaceut.7b00381.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00381", "28895735"]}, {"Citation": "Kitano A., Yamanaka O., Ikeda K., Ishida-Nishikawa I., Okada Y., Shirai K., Saika S. Tetrandrine suppresses activation of human subconjunctival fibroblasts in vitro. Curr. Eye Res. 2008;33:559\u2013565. doi: 10.1080/02713680802220817.", "ArticleIdList": ["10.1080/02713680802220817", "18600488"]}, {"Citation": "Lin T.Y., Lu C.W., Tien L.T., Chuang S.H., Wang Y.R., Chang W.H., Wang S.J. Fangchinoline inhibits glutamate release from rat cerebral cortex nerve terminals (synaptosomes) Neurochem. Int. 2009;54:506\u2013512. doi: 10.1016/j.neuint.2009.02.001.", "ArticleIdList": ["10.1016/j.neuint.2009.02.001", "19428795"]}, {"Citation": "Liu T., Zhang Z., Yu C., Zeng C., Xu X., Wu G., Huang Z., Li W. Tetrandrine antagonizes acute megakaryoblastic leukemia growth by forcing autophagy-mediated differentiation. Br. J. Pharmacol. 2017 doi: 10.1111/bph.14031.", "ArticleIdList": ["10.1111/bph.14031", "PMC5715583", "28901537"]}, {"Citation": "Meng L.H., Zhang H., Hayward L., Takemura H., Shao R.G., Pommier Y. Tetrandrine induces early g1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of g1-s-specific cyclin-dependent kinases and by inducing p53 and p21cip1. Cancer Res. 2004;64:9086\u20139092. doi: 10.1158/0008-5472.CAN-04-0313.", "ArticleIdList": ["10.1158/0008-5472.CAN-04-0313", "15604277"]}, {"Citation": "Wong V.K.W., Zeng W., Chen J., Yao X.J., Leung E.L.H., Wang Q.Q., Chiu P., Ko B.C.B., Law B.Y.K. Tetrandrine, an activator of autophagy, induces autophagic cell death via pkc-alpha inhibition and mtor-dependent mechanisms. Front. Pharmacol. 2017;8:351. doi: 10.3389/fphar.2017.00351.", "ArticleIdList": ["10.3389/fphar.2017.00351", "PMC5462963", "28642707"]}, {"Citation": "Xing Z., Zhang Y., Zhang X., Yang Y., Ma Y., Pang D. Fangchinoline induces g1 arrest in breast cancer cells through cell-cycle regulation. Phytother. Res. 2013;27:1790\u20131794. doi: 10.1002/ptr.4936.", "ArticleIdList": ["10.1002/ptr.4936", "23401195"]}, {"Citation": "Wang N., Pan W., Zhu M., Zhang M., Hao X., Liang G., Feng Y. Fangchinoline induces autophagic cell death via p53/sestrin2/ampk signalling in human hepatocellular carcinoma cells. Br. J. Pharmacol. 2011;164:731\u2013742. doi: 10.1111/j.1476-5381.2011.01349.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01349.x", "PMC3188903", "21418191"]}, {"Citation": "Lan J., Wang N., Huang L., Liu Y., Ma X., Lou H., Chen C., Feng Y., Pan W. Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma. Eur. J. Med. Chem. 2017;127:554\u2013566. doi: 10.1016/j.ejmech.2017.01.008.", "ArticleIdList": ["10.1016/j.ejmech.2017.01.008", "28109948"]}, {"Citation": "Liu Y., Huang L., Sun Q., Zhang M., Li T., Liang G., Pan W. Syntheses and anti-cancer activities of derivatives of tetrandrine and fangchinoline. Chem. Res. Chin. Univ. 2014;30:937\u2013940. doi: 10.1007/s40242-014-4240-6.", "ArticleIdList": ["10.1007/s40242-014-4240-6"]}, {"Citation": "Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000;100:57\u201370. doi: 10.1016/S0092-8674(00)81683-9.", "ArticleIdList": ["10.1016/S0092-8674(00)81683-9", "10647931"]}, {"Citation": "Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646\u2013674. doi: 10.1016/j.cell.2011.02.013.", "ArticleIdList": ["10.1016/j.cell.2011.02.013", "21376230"]}, {"Citation": "Alberts B. Molecular Biology of the Cell. Garland Science; New York, NY, USA: 2017."}, {"Citation": "Hassan M., Watari H., AbuAlmaaty A., Ohba Y., Sakuragi N. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014;2014:150845. doi: 10.1155/2014/150845.", "ArticleIdList": ["10.1155/2014/150845", "PMC4075070", "25013758"]}, {"Citation": "Caltabiano R., Leonardi R., Musumeci G., Bartoloni G., Rusu M.C., Almeida L.E., Loreto C. Apoptosis in temporomandibular joint disc with internal derangement involves mitochondrial-dependent pathways. An in vivo study. Acta Odontol. Scand. 2013;71:577\u2013583. doi: 10.3109/00016357.2012.700060.", "ArticleIdList": ["10.3109/00016357.2012.700060", "22783811"]}, {"Citation": "Ouyang L., Shi Z., Zhao S., Wang F.T., Zhou T.T., Liu B., Bao J.K. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487\u2013498. doi: 10.1111/j.1365-2184.2012.00845.x.", "ArticleIdList": ["10.1111/j.1365-2184.2012.00845.x", "PMC6496669", "23030059"]}, {"Citation": "Dickens L.S., Powley I.R., Hughes M.A., MacFarlane M. The \u2018complexities\u2019 of life and death: Death receptor signalling platforms. Exp. Cell Res. 2012;318:1269\u20131277. doi: 10.1016/j.yexcr.2012.04.005.", "ArticleIdList": ["10.1016/j.yexcr.2012.04.005", "22542855"]}, {"Citation": "Boise L.H., Gonz\u00e1lez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nu\u00f1ez G., Thompson C.B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 1993;74:597\u2013608. doi: 10.1016/0092-8674(93)90508-N.", "ArticleIdList": ["10.1016/0092-8674(93)90508-N", "8358789"]}, {"Citation": "Min F., Dong W.X. The mitochondrial pathways of apoptosis. J. Beijing Med. Univ. 2002;1:157\u2013183.", "ArticleIdList": ["0"]}, {"Citation": "Li Y.J., Zhao X., Vecchiarelli-Federico L.M., Li Y., Datti A., Cheng Y., Ben-David Y. Drug-mediated inhibition of fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}]}], "History": [{"Year": "2017", "Month": "9", "Day": "29"}, {"Year": "2017", "Month": "11", "Day": "1"}, {"Year": "2017", "Month": "11", "Day": "5"}, {"Year": "2017", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "8"}], "PublicationStatus": "epublish", "ArticleIdList": ["29117113", "PMC6150242", "10.3390/molecules22111923", "molecules22111923"]}}]}